Adrenal Function in Patients With Newly Diagnosed Lung Cancer

NCT ID: NCT00364624

Last Updated: 2009-01-16

Basic Information

• Recruitment Status: COMPLETED
• Total Enrollment: 133 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2006-08-31
• Study Completion Date: 2008-05-31

Brief Summary

Patients with newly diagnosed lung cancer may have hypofunction of the adrenal cortex either from tumour metastasis or other mechanisms. Since lung cancer patient may have to undergo stressful investigation and treatments, undetected hypofunction of the adrenal cortex may be hazardous. Knowledge of the size of the problem may help determine whether routine check is warranted.

Conditions

Lung Cancer; Adrenal Insufficiency

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: PROSPECTIVE

Eligibility Criteria

Inclusion Criteria

• Histologically proven primary lung cancer
• Newly diagnosed
• No specific treatment given
• No active infection in the previous week
• No general anesthesia in the previous week

Exclusion Criteria

• Known adrenal disease
• Receiving exogenous systemic corticosteroids
• Concomitant illness known to affect adrenal function. e.g. active TB

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Princess Margaret Hospital, Hong Kong

OTHER_GOV

Sponsor Role: lead

Responsible Party

Princess Margaret Hospital, Hong Kong

Principal Investigators

Wai C YU, MBBS

Role: PRINCIPAL_INVESTIGATOR

Princess Margaret Hospital, Hong Kong

Locations

Department of Medicine, Princess Margaret Hospital

Kowloon, Hong Kong SAR, China

Countries

China

Other Identifiers

KW/FR/06-008

Identifier Type: -

Identifier Source: org_study_id